Daiichi Sankyo Co Ltd Sustainability Reports
Daiichi Sankyo Company, Limited is a global biopharmaceutical enterprise engaged in the research, development, manufacturing, and marketing of innovative medical products, with a primary strategic focus on oncology therapeutics and antibody-drug conjugate technology.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
ISIN: JP3475350009
34 reports from 2009 to 2025